Previous Close | 64.97 |
1-Year Change | 518.17% |
6-Months Change | 363.08% |
3-Months Change | 112.95% |
Moving Avg (50d) | 53.069 |
Moving Avg (200d) | 26.529 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 3.2B |
Beta (3-Years) | 1.24 |
Revenue Growth (ttm) | -3.2% |
Net Profit Margin (ttm) | -185.1% |
Return On Assets (ttm) | -23.7% |
EPS (ttm) | -1.29 |
PE Ratio (ttm) | -50.36 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |